Vnitr Lek 2013, 59(3):218-223

Problematic issues related to screening for diabetic retinopathy

P. Skalická*, B. Kalvodová
Oční klinika 1. lékařské fakulty UK a VFN Praha, přednostka doc. MUDr. Bohdana Kalvodová, CSc.

The aim of this paper is to highlight the importance of screening for diabetic retinopathy and the education of diabetic patients. The key prerequisite of an effective screening is close collaboration between health care professionals. Successful screening detects DR at early stages and helps to prevent severe visual loss. Two cases of proliferative DR exhibiting the most serious complications (vitreous haemorrhage, traction retinal detachment and combined traction and rhegmatogenous retinal detachment, neovascular glaucoma) are reported. The first comorbid patient lost her vision despite the adequate treatment. The second patient was successfully managed with pars plana vitrectomy with final visual acuity better to the preoperative value.

Keywords: diabetic retinopathy; screening; indirect biomicroscopy

Received: January 24, 2013; Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skalická P, Kalvodová B. Problematic issues related to screening for diabetic retinopathy. Vnitr Lek. 2013;59(3):218-223.
Download citation

References

  1. Kalvodová B. Screening diabetické retinopatie v ČR - guideline. Čes slov Oftal 2002; 58: 3-10.
  2. Sosna T. et al. Diabetická retinopatie - rizikové faktory, prevence a terapie. Čes slov Oftal 2010; 66: 195-203.
  3. Kalvodová B et al. Diagnostika a léčba diabetické retinopatie a jejích komplikací. DMEV Diabetologie 2002; 5: 214-218.
  4. Standardy pro diagnostiku a léčbu diabetické retinopatie a jejích komplikací. DMEV Diabetologie 2004; 7: 22-25.
  5. Ústav zdravotnických informací a statistiky ČR. Péče o nemocné s cukrovkou 2011: 8.
  6. Zhang X et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010; 304: 649-656. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.